Regorafenib and Ruthenium Complex Combination Inhibit Cancer Cell Growth by Targeting PI3K/AKT/ERK Signalling in Colorectal Cancer Cells

Cancer is one of the leading cause of lethality worldwide, CRC being the third most common cancer reported worldwide, with 1.85 million cases and 850,000 deaths annually. As in all other cancers, kinases are one of the major enzymes that play an essential role in the incidence and progression of CRC...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Deepu, Rasool, Fayyaz, Bharti, Manjri, Vyas, Komal M., Magani, Sri Krishna Jayadev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820863/
https://www.ncbi.nlm.nih.gov/pubmed/36614133
http://dx.doi.org/10.3390/ijms24010686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820863/
https://www.ncbi.nlm.nih.gov/pubmed/36614133
http://dx.doi.org/10.3390/ijms24010686

Ejemplares similares